Unassociated Document
Todd
J. Emmerman
|
todd.emmerman@kattenlaw.com
|
212.940.8873
direct
|
212.894.5873
fax
|
January
28, 2011
Via Edgar and Federal
Express
United
States Securities and Exchange Commission
Division
of Corporation Finance
100 F
Street, N.E.
Washington,
D.C. 20549-7010
Attn:
Erin Jaskot
|
Registration
Statement on Form S-3
|
Dear Ms. Jaskot:
Set forth
below is the response on behalf of Essex Rental Corp. (“Essex”) to the comments
of the staff (the “Staff”) of the Securities and Exchange Commission (the
“Commission”) contained in the letter, dated January 13, 2011 (the “Comment
Letter”), concerning Essex’s Registration Statement on Form S-3 (the
“Registration Statement”) filed with the Commission on December 23,
2010. In this letter, the words “we”, “us” and “our” refer to Essex
unless the context otherwise requires.
For your
convenience and to facilitate your review, marked copies of the Registration
Statement, which have been revised in accordance with our responses below and
otherwise updated, are being delivered to you separately.
General
|
1.
|
We note that you are proposing
to register the resale of up to 10,695,363 shares of your common stock on
behalf of the selling stockholders named in your registration
statement. We further note that you are proposing to register
this resale on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, as amended. Given the size of this
offering relative to the number of outstanding shares held by
non-affiliates, as well as the nature of the selling stockholders, we
believe this transaction might be a primary offering. Because
you do not appear to be eligible to conduct a primary offering on Form
S-3, you are not eligible to conduct a primary at-the-market offering
under Rule 415(a)(4). If you disagree with our analysis, please
tell us why you believe you can rely on Rule 415(a)(1)(i) for this
transaction. In your analysis, you may wish to address the
following factors: how long the selling stockholders have held the shares,
the circumstances under which they received them, their relationship to
the company, the amount of shares involved, whether they are in the
business of underwriting securities, and finally, whether under all the
circumstances it appears that they are acting as a conduit for the
company. See Question 612.09 of the Compliance & Disclosure
Interpretations for Securities Act Rules, which are available on our
website.
|
Response:
As a preliminary matter, we note that, after giving effect to the issuance of
3,300,000 shares of Essex common stock on November 24, 2010, and based on recent
closing prices for Essex’s common stock, we believe that Essex is eligible to
conduct a primary offering on Form S-3 pursuant to General Instruction B.1 of
Form S-3.
Nonetheless,
we have analyzed the offering contemplated by the Registration Statement under
Rule 415(a)(1)(i) and the factors noted in the Staff’s comment and in Question
612.09 of the Compliance and Disclosure Interpretations for Securities Act Rules
(the “C&DI”). Based
on the totality of the circumstances, we respectfully submit that the offering
by the selling stockholders identified in the Registration Statement is a true
secondary offering and the selling stockholders are not acting as underwriters
or conduits for Essex. While we recognize that the number of shares
of common stock being registered on behalf of the selling stockholders is
substantial relative to Essex's public float, we do not believe that this fact
alone is determinative. Rather, we believe the magnitude of the
offering is outweighed by the following factors:
How Long the Selling Shareholders
Have Held the Shares.
As
detailed below, approximately 70% of the 10,695,363 shares (the "Total Shares") being
registered in the Registration Statement were acquired, or represent shares
underlying convertible securities that were acquired, over two
years ago. The balance of the Total Shares were acquired in a
November 2010 PIPE transaction effected by Essex to finance an acquisition by
Essex completed at such time.
The
holding period for each of the 10,695,363 Total Shares included in the
Registration Statement is described below.
The Levy
Shares. The 3,467,752 shares being registered on behalf of
Laurence Levy, Edward Levy and Jane Levy (the “Levy Shares”) were
acquired, or represent issued and unissued shares underlying warrants acquired,
prior to or concurrent with Essex’s March 2007 initial public
offering.
The Kirtland
Shares. The 3,294,700 shares being registered on behalf of
Kirtland Capital Partners (the “Kirtland Shares”)
were acquired in open market or private purchases between May 2008 and November
2008.
The Management
Shares. The 632,911 shares being registered on behalf of
Ronald Schad, Martin Kroll, William Erwin and William O’Rourke (such shares, the
"Management
Shares" and such selling stockholders, the "Management Holders")
represent shares underlying exchangeable membership interests of Essex Holdings
LLC that were issued in October 2008.
We
believe that the substantial length of time that the above selling stockholders
have held their shares, or securities convertible into or exchangeable for
shares, and the commensurate period of time that such stockholders have been "at
risk" with respect to their investment, more than adequately establishes that
the offering contemplated by the Registration Statement on behalf of such
stockholders is “solely by or on behalf of a person or persons other than the
registrant, a subsidiary of the registrant or a person of which the registrant
is a subsidiary” in accordance with the requirements of Rule
415(a)(1)(i).
The PIPE
Shares. The 3,300,000 shares (the “PIPE Shares”) being
registered on behalf of Calm Waters Partnership, Matthew Campbell, Daeg Partners
LP, Equitable Holding Corp., KC Gamma Opportunity Fund, LP and T. Rowe Price
Small-Cap Value Fund (the “PIPE Investors”) were
acquired in November 2010 pursuant to binding subscription agreements entered
into in October 2010.
We
believe that the Staff's guidance in Securities Act Forms Compliance and
Disclosure Interpretation Question 116.19 (“C&DI 116.19”),
that a valid secondary offering may occur immediately following the closing of a
private placement without the satisfaction of any required holding period, is
instructive on the issue of registration of the PIPE Shares. The PIPE
Shares were issued pursuant to a valid private placement under Section 4(2) of
the Securities Act, and the PIPE Investors have bore the market risk of their
investment since they signed binding subscription agreements in October
2010. Moreover, given the historical limited trading volume for
Essex's common stock, as a practical matter, the PIPE Investors will likely
continue to bear the risk of a significant portion of their investment for some
time. We believe that the exposure to such market risk, together with
the other factors noted below, distinguishes the PIPE Investors from an
underwriter, and that the offering contemplated by the Registration Statement on
behalf of such stockholders meets the requirements of Rule
415(a)(1)(i).
The Circumstances Under Which the
Selling Stockholders Received the Shares.
The
circumstances under which each selling stockholder received its shares are
described below.
The Levy
Shares. 1,440,000 of the Levy Shares were issued in a private
placement pursuant to Section 4(2) of the Securities Act prior to
Essex’s
initial public offering and 1,260,000 of the Levy Shares were issued to Messrs.
Levy and Levy as stock dividends prior to Essex’s initial public
offering. In connection with Essex's initial public offering, such
stock dividend shares and private placement shares were deposited in escrow and
could not be released from escrow or sold prior to the one year anniversary of
the date on which Essex completed an acquisition of an operating
business. One objective of the escrow arrangement was to demonstrate
to public stockholders Messrs. Levy and Levy’s long-term commitment to Essex and
to align their interests with the long-term interests of Essex's
stockholders. We believe these circumstances are indicative of
Messrs. Levy and Levy’s intention to hold the shares for long-term investment
purposes, rather than as a conduit for a distribution by Essex.
The
balance of the Levy Shares were or will be issued upon the exercise of warrants
which were issued in a private placement pursuant to Section 4(2) of the
Securities Act. The warrants are exercisable at a fixed exercise
price. In connection with such issuance, Messrs. Levy and Levy made
specific representations to Essex that they were acquiring such securities for
their own accounts and not with a view towards, or for resale in connection
with, a public sale or distribution. The Company is not aware of any evidence
that would indicate that these specific representations were false.
The Kirtland
Shares. The Kirtland Shares were acquired by Kirtland Capital
Partners and its affiliates in open market or privately negotiated transactions
from third parties that had no relationship with Essex (other than as
shareholders). Essex did not participate in any such transactions and
Essex did not receive any proceeds from the sale of such shares to
Kirtland. In our view, the circumstances of such acquisitions contain
none of the indicia of a primary offering. The Kirtland Shares are
being included in the Registration Statement because Kirtland Capital Partners
may be deemed to be an affiliate of Essex in light of its significant share
holdings as well as the fact that, as discussed below, one of its affiliates
became a member of our board of directors in September 2009.
The Management
Shares. The Management Shares are issuable upon exchange of
membership interests in Essex's subsidiary, Essex Holdings. The
Management Holders held membership interests in Essex Holdings at the time of
Essex's acquisition of Essex Holdings in October 2008. At the time of
such acquisition and as part of the consideration therefor, the terms of the
membership interests were amended to give the Management Holders the right to
exchange their membership interests for shares of Essex common stock at a fixed
exchange ratio, and to provide the Management Holders with certain economic
rights of share ownership pending the exchange of membership interests for
shares. The Management Holders’ investment in Essex was structured in
this manner to facilitate a continuing investment in Essex’s business on a tax
deferred basis. The Management Holders agreed at the time of
receiving such exchange rights to not sell any of the Management Shares for a
two year period following completion of Essex's acquisition of Essex
Holdings. One objective of this element of the transaction was to
demonstrate to public stockholders the Management Holders' long-term commitment
to Essex and to align their interests with the long-term interests of Essex's
stockholders. We believe these circumstances are indicative of each
Management Holder's intention to hold their shares for long-term investment
purposes, rather than as a conduit for a distribution by Essex.
The PIPE
Shares. The PIPE Shares were acquired in a private placement
pursuant to Section 4(2) of the Securities Act. The PIPE Investors
made specific representations to Essex that they were acquiring the shares for
their own accounts and not with a view towards, or for resale in connection
with, a public sale or distribution. Essex is not aware of any evidence that
would indicate that these specific representations were false. The
PIPE Shares were sold by Essex to finance a specific acquisition of assets in a
bankruptcy proceeding. The PIPE Investors irrevocably committed to
purchase the PIPE Shares concurrent with consummation of the asset acquisition
and the PIPE Investors were not entitled to any purchase price or other
adjustment following public announcement of such acquisition or of the
PIPE. Accordingly, the PIPE Investors, in addition to normal market
risk associated with an investment in the shares, were required to bear the
market risk associated with announcement of the asset acquisition and PIPE by
Essex. We believe that the exposure to such enhanced market risk
exposure, together with the other factors noted herein, strongly distinguishes
the PIPE Investors from an underwriter.
The Selling Stockholders’
Relationship to the Issuer.
None of
the selling stockholders is acting on behalf of Essex with respect to the shares
being registered for resale under the Registration Statement, and Essex has no
contractual, legal or other relationship with any of the selling stockholders
that would control the timing, nature and amount of resales of such shares or
whether such shares are even resold at all under the Registration Statement,
other than Essex’s obligation to register for resale the shares covered by
the Registration Statement. In addition, Essex would not receive any
of the proceeds from any resales of such shares by any selling stockholders
under the Registration Statement. Rather, all proceeds received from
any such resales would accrue to the benefit of the selling
stockholders.
We also
note that, to our knowledge, none of the selling stockholders is a member of a
“group” with any other selling stockholder within the meaning of Section
13(d)(3)of the Exchange Act or Rule 13d-5(b) thereunder. Nor is Essex
aware of any information that would lead it to conlude that the selling
stockholders are not acting independently of one another.
The
relationship of each selling stockholder to Essex is described
below.
The Levy
Shares. The Levy Shares are owned by Laurence Levy, Edward
Levy and Jane Levy. Laurence Levy and Edward Levy are each members of
Essex’s board of directors and each was a founding stockholder of
Essex. Edward Levy is not related to Laurence Levy. Jane
Levy is Laurence Levy's sister to whom Laurence Levy transferred 3,000 founders
shares as a bona fide gift for no consideration. Based on their
relationships with Essex, Messrs. Levy and Levy are subject to Essex’s internal
policies regarding insider trading and Section 16 of the Securities Exchange Act
of 1934. If the Registration Statement is declared effective, these
internal policies and regulations may limit the ability of these selling
stockholders to sell their shares in a manner that distinguishes these
shareholders from an underwriter.
The Kirtland
Shares. The Kirtland Shares are beneficially owned by Kirtland
Capital Partners. Kirtland Capital Partners was the majority owner of
Essex Holdings prior to Essex's acquisition of Essex Holdings in October
2008. Kirtland may be deemed to be an affiliate of Essex as a result
of its significant share holdings in Essex as well as the fact that one of
Essex’s directors, John Nestor, is an affiliate of Kirtland Capital
Partners. Mr. Nestor became a member of Essex’s board of directors in
September 2009, ten months after Kirtland Capital Partners’ last acquisition of
Essex shares. Kirtland Capital Partners does not have a contractual
or other right to appoint a member of Essex’s board of directors; Mr. Nestor was
asked to join the Essex board as a result of his intimate knowledge of Essex's
business and the industry in which it operates as well as for his general
business acumen and experience. Based on its shareholdings, Kirtland
Capital Partners is subject to Section 16 of the Securities Exchange Act of
1934. If the Registration Statement is declared effective, these
regulations may limit the ability of Kirtland to sell its shares in a manner
that distinguishes Kirtland from an underwriter.
The Management
Shares. The Management shares are owned by Ronald Schad,
Martin Kroll, William O'Rourke and William Erwin. Mr. Schad is
Essex’s Chief Executive Officer and a member of Essex’s board of
directors. Martin Kroll serves as Essex’s Chief Financial
Officer and Senior Vice President. William O’Rourke and William Erwin
are both employees of Essex Crane, a subsidiary of Essex. Messrs
Schad, Kroll, Erwin and O’Rourke were members of Essex Holdings prior to its
acquisition by Essex. Based on their relationship with Essex, each of
Messrs. Schad, Kroll, O'Rourke and Erwin is subject to Essex’s internal policies
regarding insider trading and, with the exceptions of Messrs. Erwin and
O’Rourke, Section 16 of the Securities Exchange Act of 1934. If the
Registration Statement is declared effective, these regulations and internal
policies will limit the ability of these selling stockholders from selling their
shares in a manner that distinguishes these shareholders from an
underwriter.
The PIPE
Shares. The PIPE Investors consist of various individuals and
entities that invested in our private placement that closed in November 2010.
With the exception of T. Rowe Price Small-Cap Value Fund and Calm Waters
Partnership, which own approximately 8.3% and 4.6%, respectively, each PIPE
Investor owns less than 1% of Essex’s outstanding common stock. None
of these investors is an affiliate of Essex and Essex has no contractual or
other relationships with such investors other than Essex’s obligation to
register the shares they purchased in our private placement.
The
Amount of Shares Involved.
While the
number of Total Shares is large relative to Essex’s public float, we do not
believe that in this case such factor is indicative of a primary
distribution. Essex’s public float is relatively small compared to
Essex's total capitalization, representing just 65% of Essex’s total shares
outstanding as of January 26, 2011. The ratio of shares included in
the Registration Statement to Essex’s public float is reflective of the fact
that Essex does not have a widespread shareholder base among
non-affiliates.
With
respect to the PIPE Shares, we note that the amount of common stock sold in the
private placement was reflective of Essex’s immediate financing needs, not an
intent to engage in a distribution. The proceeds of Essex’s private
placement were used to fund a portion of the cash purchase price of its
acquisition of the assets of Coast Crane Company in a bankruptcy
auction. As a part of the auction procedures, Essex was required to
demonstrate that it had the wherewithal to unconditionally finance its
acquisition. Under the circumstances, a PIPE was one of a limited
number of options for Essex to raise sufficient capital to submit such an
unconditional bid and to complete the acquisition on a timely
basis.
Regardless
of the percentage of Essex’s Public Float sought to be registered, it is
important to note that the amount of shares being registered is only one factor
cited in the C&DI to be considered in evaluating whether an offering is
being conducted on behalf of an issuer rather than on behalf of the
issuer. We believe the Staff’s guidance supports this
position. Compliance and Disclosure Interpretation for Securities Act
Forms number 216.14 provides
Secondary
sales by affiliates may be made under General Instruction I.B.3 to Form S-3,
even in cases where the affiliate owns more than 50% of the issuer's securities,
unless the facts and circumstances indicate that the affiliate is acting as an
underwriter or by or on behalf of the issuer.
Similarly,
Compliance and Disclosure Interpretation for Securities Act Rules
number 612.12 provides that a controlling person of an issuer who
owns a 73% block of shares could conduct an at-the-market offering under Rule
415(a)(4).
Giving
undue weight to the number of shares to be registered would also be inconsistent
with statements in Release No. 33-8878 (the “Release”) which
amended Form S-3 to include Instruction I.B.6. The Release acknowledged the
Staff’s historical position that “Form S-3 has for many years allowed
registrants to conduct secondary offerings on the form irrespective of public
float, so long as the securities offered thereby were listed securities.” The
Release also stated that the use of Instruction I.B.6. is “not meant to be
mutually exclusive. Rather, it is designed to provide added flexibility to
smaller companies by giving them supplemental avenues of capital formation.” The
Release recognized the importance of private placements to small companies and
permits companies to continue to register shares for resale by selling
stockholders on Form S-3 even if the company has also conducted a primary
offering on Form S-3 under Instruction I.B.6.
Whether
the Sellers are in the Business of Underwriting Securities.
Essex
does not believe that any of the selling stockholders are in the business of
underwriting securities. As to selling stockholders who are not
affiliated with Essex, we note that each PIPE Investor represented to Essex that
such PIPE Investor acquired its shares for its own account, for investment and
not with a view to resale or distribution to others in whole or in
part. Each PIPE Investor also represented that it had no
agreement or arrangement, formal or informal, with any person to sell or
transfer all or any part of the shares; and the PIPE Investor had no plans to
enter into any such agreement or arrangement. Essex is aware that
certain affiliates of one PIPE Investor, T. Rowe Price Small-Cap Value Fund, may
act as the principal underwriter of shares of the funds in the T. Rowe Price
fund family. However, Essex has been advised the such affiliated
entities do not engage in underwriting or market making activities involving
individual securities.
Whether
under all the circumstances it appears that the seller is acting as a conduit
for the issuer.
We
respectfully submit that none of the selling stockholders is acting as an
underwriter or a conduit for Essex.
Essex is
not aware of any evidence that any selling stockholder identified in the
Registration Statement acquired its shares with any plan or intention, or
presently has any plan or intention, to act in concert with any other selling
stockholder to effect a distribution of Essex shares. Nor is Essex
aware of any evidence that would indicate that a distribution would occur if the
Registration Statement is declared effective. Under the Commission’s own rules,
a distribution requires special selling efforts. Rule 100(b) of
Regulation M defines a distribution as “an offering of securities, whether or
not subject to registration under the Securities Act, that is distinguished from
ordinary trading transactions by the magnitude of the offering and the presence
of special selling efforts and selling methods.” Essex is not aware of any
evidence that would indicate that any special selling efforts or selling methods
(such as any road shows or other actions to condition the market for Essex’s
common stock) by or on behalf of any selling stockholder has taken place or
would take place if the Registration Statement is declared
effective.
In
addition, the selling stockholders acquired their shares at various times and
have held their shares for periods of time that are inconsistent with the
activities of an underwriter or conduit for a distribution. To the
extent that any selling stockholder were to sell shares pursuant to the
Registration Statement, the selling stockholder would retain all proceeds
therefrom without any remuneration or other benefit to Essex.
The
selling stockholders that are affiliated with Essex are long-term investors with
a demonstrated long-term commitment to Essex, as evidenced by various factors,
including the absence of any sales of Essex common stock by any of such
affiliates to date and the absence of any hedging arrangements that would
mitigate the risks associated with the ownership of Essex common
stock.
We find
no evidence that the PIPE Investors purchased Essex’s common stock in Essex’s
private placement to facilitate a continuous at-the-market offering on the part
of Essex. Rather, the purpose of the financing was to provide Essex
with cash necessary to complete an acquisition. The PIPE Shares were
sold at a fixed price and the PIPE Investors have borne the risks associated
with ownership of shares for over two months, including during a period of
extraordinary public announcements by Essex.
Finally,
in light of the substantial evidence of investment intent on the part of the
selling stockholders, limiting Essex’s ability to register the resale of the
Total Shares on behalf of the selling stockholders would not further any public
policy interests. The confluence of all of these facts and circumstances drives
the conclusion that a resale by the selling stockholders whenever it occurs is
not a primary offering.
Based on
the foregoing facts and circumstances we do not see any reason why the selling
stockholders should be treated as “underwriters” within the meaning of Section
2(a)(11) of the Securities Act. On the basis of the foregoing, we respectfully
request that the Staff not impose a cap on the number of resale shares allowed
to be registered in the Registration Statement, as doing so would give primacy
to only one of the elements of an CD&I 612.09 analysis, and would contradict
the Release’s intention of providing additional flexibility for financing
options for small companies like Essex. We therefore respectfully request the
Staff to permit Essex to effect the registration of the resale of the Total
Shares pursuant to the Registration Statement and Rule
415(a)(1)(i).
Selling Stockholders, page
12
|
2.
|
Please include a complete
description of the transactions in which Kirtland Capital Partners
acquired its shares. In particular, please identify the
affiliates of Kirtland Capital Partners, the dates of the transactions,
the number of shares purchased in each transaction, and the purchase
price, if any. In addition, we are unable to locate the Current
Report on Form 8-K filed on December 1, 2008, as referenced in your
disclosure. Please
advise.
|
Response: We
have revised our disclosure to include a description of the transactions in
which Kirtland Capital Partners (“Kirtland”) acquired its shares, including by
identifying the affiliates of Kirtland that acquired the shares and the dates
on, and purchase prices at, which Kirtland acquired its shares. We
have also revised the reference to a Form 8-K filed on December 1, 2008 to
reflect the correct filing date of November 6, 2008.
|
3.
|
Please identify the dates of
the transactions in which Laurence Levy and Edward Levy acquired their
shares and warrants, and the purchase price, if any, of such
shares.
|
Response: We
have revised our disclosure to include the dates of the transactions in which
Laurence Levy and Edward Levy acquired their common stock and warrants, as well
as the purchase price for such securities, to the extent
applicable.
|
4.
|
Please identify by name the
natural person(s) who exercise voting or investment control or both with
respect to the shares held by the following selling
stockholders:
|
|
·
|
Equitable Holdings
Corp.;
|
|
·
|
KC Gamma Opportunity Fund,
LP;
|
|
·
|
Kirtland Capital Partners
Ltd.; and
|
|
·
|
T. Rowe Price Small-Cap Value
Fund
|
See Question 140.02 of the Division's
Compliance & Disclosure Interpretations for Regulation
S-K.
Response:
We have added disclosure responsive to the Staff’s comment in the footnotes to
the selling stockholder table beginning on page 14 of the Registration
Statement.
|
5.
|
With regard to Equitable
Holdings Corp., KC Gamma Opportunity Fund, LP, Kirtland Capital Partners
Ltd., and T. Rowe Price Small-Cap Value Fund, please tell us whether any
of these stockholders are broker-dealers or affiliates of a
broker-dealer.
|
|
·
|
For each of the aforementioned
stockholders that is a broker-dealer, the prospectus should state that the
stockholder is an
underwriter.
|
|
·
|
For each of the aforementioned
stockholders that is an affiliate of a broker-dealer, the prospectus
should state that (a) the stockholder purchased in the ordinary course of
business and (b) at the time of the purchase of the shares to be resold,
the stockholder had no agreements or understandings, directly or
indirectly, with any person to distribute the shares. However,
if the stockholder cannot provide these representations, then the
prospectus should state that the stockholder is an
underwriter.
|
Notwithstanding the foregoing,
broker-dealers and their affiliates who received their securities as
compensation for underwriting activities need not be identified as
underwriters.
Response: We
advise the staff that, based on representations made to Essex by each of
Equitable Holding Corp., KC Gamma Opportunity Fund, LP and Kirtland Capital
Partners Ltd., no such selling stockholder is a broker-dealer or an affiliate of
a broker-dealer. With respect to T. Rowe Price Small-Cap Value Fund,
we have added disclosure responsive to the Staff’s comment to footnote 10 of the
selling stockholder table beginning on page 14 of the Registration
Statement.
Signatures, page
23
|
6.
|
Please include the signature
of your controller or principal accounting officer. See
Instruction 1 to Signatures on Form
S-3.
|
Response:
We have revised the signature page of the Registration Statement to clarify that
the Chief Financial Officer of Essex has executed the Registration Statement as
the principal accounting officer of Essex.
Exhibits
|
7.
|
We note that the exchange
rights for the membership interests in Essex Holdings LLC were created
pursuant to the Amended and Restated Limited Liability Company Agreement
of Essex Holdings LLC, dated October 31, 2008, among Essex Rental Corp.,
Ronald Schad, Martin Kroll, William Erwin and William
O'Rourke. Please include this agreement as an exhibit to your
registration statement.
|
Response: We
have added the Amended and Restated Limited Liability Company Agreement of Essex
Holdings, LLC, dated October 31, 2008, among Essex Rental Corp., Ronald Schad,
Martin Kroll, William Erwin and William O’Rourke as Exhibit 4.4 of the
Registration Statement.
* * * * *
In
submitting this response letter Essex has authorized me to acknowledge on its
behalf that: (i) should the Commission or the staff, acting pursuant to
delegated authority, declare the filing effective, it does not foreclose the
Commission from taking any action with respect to the filing; (ii) the action of
the Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve Essex from its full
responsibility for the adequacy and accuracy of the disclosure in the filing,
and (iii) Essex will not assert the declaration of effectiveness as a defense in
any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
If you
have any questions regarding any of our responses or the Registration Statement,
as amended, please feel free to call me (212-940-8873).
Regards,
|
|
/s/
Todd J. Emmerman
|
Todd
J. Emmerman
|